NewcelX (NCEL) Other Non-Current Assets (2021 - 2025)
NewcelX (NCEL) posted quarterly Other Non-Current Assets of $283.0 for Q2 2025, little changed quarter-over-quarter from $283.0 in Q4 2024.
NewcelX (NCEL) Other Non-Current Assets (2021 - 2025) Analysis & Trends
NewcelX (NCEL) has reported Other Non-Current Assets for 5 consecutive years, with $283.0 the latest figure, recorded in Q2 2025.
- In Q2 2025, Other Non-Current Assets changed N/A year-over-year to $283.0; the TTM figure through Jun 2025 stood at $283.0 (changed N/A YoY), while the FY2024 annual figure was $283.0, down 98.32% from the prior year.
- Other Non-Current Assets was little changed at $283.0 in Q2 2025 per NCEL's latest filing, from $283.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $16885.0 in Q4 2023 and bottomed at $283.0 in Q4 2024.
- Historically, Other Non-Current Assets has averaged $9418.7 across 5 years, with a median of $12044.0 in 2021.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets jumped 39.05% — and 2024, when it plunged 98.32%.
- NewcelX's Other Non-Current Assets stood at $12044.0 in 2021, then gained by 0.82% to $12143.0 in 2022, then surged by 39.05% to $16885.0 in 2023, then slumped by 98.32% to $283.0 in 2024, then changed by 0.0% to $283.0 in 2025.
- Business Quant data shows NCEL's Other Non-Current Assets at $283.0 in Q2 2025, $283.0 in Q4 2024, and $16885.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | NewcelX | 12.54 Mn | 10.34 Mn | - | 296,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 283.00 |
| Dec 31, 2024 | 283.00 |
| Dec 31, 2023 | 16,885.00 |
| Jun 30, 2023 | 12,558.00 |
| Dec 31, 2022 | 12,143.00 |
| Jun 30, 2022 | 11,735.00 |
| Dec 31, 2021 | 12,044.00 |